Pa. Med Society: pposed to legalizing marijuana for recreational use

More study needed on medicinal uses
Nominate a Top Woman in Business. Click here. Nominate an NEPA business professional under 40. Click here.

20 Under 40: JenniferDessoye

Photo: N/A, License: N/A, Created: 2016:11:17 11:10:02

Dr. Jennifer Dessoye is assistant professor of occupational therapy at Misericordia University and owner of Bright Beginnings Early Learning Academy (BBELA). Discontent with the early education curriculum and understanding of human development and neurolo (read more)

20 Under 40: Amy Hlavaty Belcher

Photo: N/A, License: N/A, Created: 2016:11:09 13:55:46

Amy Hlavaty Belcher, 39, owner and artistic director of Abrabesque Academy of Dancing, believes that for those who have been given much, much is expected. “I just try hard to do my best,” she said. I have been blessed with many opportunities and many gift (read more)

20 Under 40: Christopher Hetro

Photo: N/A, License: N/A, Created: 2016:11:14 11:21:35

Chris Hetro, 33, works hard and plays hard. “A strong work ethic is important, but finding balance outside of work is important because life is too short and you need to enjoy it,” he explained. As an electrical engineer and project manager at Borton-Laws (read more)

20 Under 40: C. David Pedri

Photo: N/A, License: N/A, Created: 2016:11:14 15:19:17

For attorney C. David Pedri, 37, it’s all about a combination of qualities that contribute to success. “My philosophy is simple: be open and honest, treat people the way you would want to be treated, with respect, and work hard to attain your dreams. The (read more)

20 Under 40: Ed Frable

Photo: N/A, License: N/A, Created: 2016:11:09 11:13:04

Ed Frable, 28, believes “if I work hard and stick to my word, good things will happen. My crew will not be deterred. We will re-evaluate our game plan and not give up until the job is complete,” explained Frable, the owner/operator of Ed Frable Constructi (read more)

20 Under 40: William H. Bender II

Photo: N/A, License: N/A, Created: 2016:11:16 13:11:08

William H. Bender II, CFP, CIMA, CRPC, loves what he does. “I’m lucky. I come to work every day excited to help the people and institutions we work with,” explained Bender, 34, first vice president at Bender Wealth Management Group, Merrill Lynch. The fam (read more)

20 Under 40: Angelo Venditti

Photo: N/A, License: N/A, Created: 2016:11:14 16:09:11

Angelo Venditti, 38, heard a call to the helping professions early on. Geisinger Northeast’s chief nursing officer answer was to volunteer for his local fire company. After high school, he became a paramedic, then enrolled in nursing school. Three years a (read more)

20 Under 40: Donald Mammano

Photo: N/A, License: N/A, Created: 2016:11:17 12:38:37

At 20, Donald Mammano began his own company, while attending the University of Scranton. Mammano, now 33, and president of DFM Properties, recalls, as a youngster, holding a flashlight while his father fixed the kitchen sink. “From that point on I was fas (read more)

20 Under 40: William J. Fennie III

Photo: N/A, License: N/A, Created: 2016:11:15 09:50:19

William J. Fennie III, 27, is always knocking on the proverbial door, because he knows one day, one will open. As an investment specialist with Integrated Capital Management (iCM) he cannot take “no” for an answer. “I make cold calls every day to invite f (read more)

20 Under 40: Marcus Magyar

Photo: N/A, License: N/A, Created: 2016:11:14 13:25:24

As an advisor at CAPTRUST Financial Advisors, Marcus N. Magyar, CFP, 30, provides comprehensive wealth management and investment portfolio services to business owners, executives, families and high-net worth individuals. His multi-disciplinary team of pro (read more)

20 Under 40: Heather Davis

Photo: N/A, License: N/A, Created: 2016:11:10 13:34:44

Heather M. Davis, 33, director of marketing and communication, is responsible for creating, overseeing and implementing a strategic marketing and comprehensive communications plan for The Commonwealth Medical College (TCMC). She is also responsible for pr (read more)

20 Under 40: Alexandria Duffney

Photo: N/A, License: N/A, Created: 2016:11:14 14:24:50

Alexandria Duffney, 30, is competitive by nature and loves a good challenge. These qualities have led her to her position as associate director of graduate admission at Wilkes University. Here she works with prospective students interested in enrolling in (read more)

20 Under 40: John Culkin

Photo: N/A, License: N/A, Created: 2016:11:07 17:18:26

John Culkin’s tenets inform: “Less haste equal more speed; the same boiling water that softens the potato hardens the egg, it is all about what you are made of, not the circumstances surrounding you; and don’t ask someone to walk a mile in your shoes, bef (read more)

20 Under 40: Conor O'Brien

Photo: N/A, License: N/A, Created: 2016:11:14 17:19:58

“What could be worse than getting to the end of your life and realizing you hadn’t lived it,” mused Conor O’Brien.” As co-founder and executive director of the Scranton Fringe Festival, O’Brien, 25, is responsible for leading the development of the overal (read more)

20 Under 40: Jessica Siegfried

Photo: N/A, License: N/A, Created: 2016:11:10 14:12:08

Jessica Siegfried, 38, is senior designer with BlackOut Design Inc., where she is responsible for all creative design at the full-service agency, from traditional branding and print to collateral and front end web design. “I’ve always had an interest in t (read more)

20 Under 40: David Johns

Photo: N/A, License: N/A, Created: 2016:11:08 10:15:37

David Johns’ career path has been shaped by his diverse experiences. As director of structural engineering at Greenman-Pedersen Inc., Moosic, Johns, 39, ensures that his engineering and consultant teams provide clients with their best effort. “We complete (read more)

20 Under 40: Robyn Jones

Photo: N/A, License: N/A, Created: 2016:11:14 12:41:32

Robyn Jones, 38, president of ReferLocal LLC, has learned just as many lessons from her business successes as she’s had from her failures — and she believes it’s important to share that knowledge with her employees. After graduating from American Universi (read more)

20 Under 40: Nisha Arora

Photo: N/A, License: N/A, Created: 2016:11:14 10:02:06

Nisha Arora, 36, tries to be the best version of herself every day. As general counsel for ERA One Source Realty Inc., she realized she cannot control other’s behavior so “I try to focus on myself and how I can be better,” she explained. Arora’s responsib (read more)

20 Under 40: Justin Sandy

Photo: N/A, License: N/A, Created: 2016:11:10 14:59:27

Starting at a young age in Hazleton, Justin C. Sandy, 33, found a passion for running. He became a member then a coach for Misericordia University’s cross country and track and field programs. “It was at Misericordia that I also garnered the profound sati (read more)

20 Under 40: Dr. Ariane Conaboy

Photo: N/A, License: N/A, Created: 2016:11:16 09:38:07

As a doctor of internal medicine at Physicians Health Alliance, Dr. Ariane M. Conaboy, 34, realizes the importance of human life and how fragile it can be at times. Conaboy graduated from Scranton Prep and the University of Scranton with a double major in (read more)

Find us on Facebook!

Photo: N/A, License: N/A

"Like" us on Facebook for all of the latest news! (read more)

Follow us on Twitter!

Photo: N/A, License: N/A

Follow us for constant updates! (read more)

Article Tools

Font size
+
Share This
EmailFacebookTwitter


Good morning, Chairman McIlhinney, Chairman Boscola, and members of the Senate Law and Justice Committee, I am Michael R. Fraser, PhD, CAE, Executive Vice President and Chief Executive Officer of the Pennsylvania Medical Society. Thank you for the opportunity to present the Medical Society’s views on Senate Bill 1182, which would legalize marijuana for medical use in Pennsylvania. To start, I would like to point out to the Committee that I am not a medical doctor. Unfortunately, our physician leadership was unable to attend today’s hearing and therefore I may have to refer any questions of a medical nature to our physician leadership.
Let me begin by acknowledging that the topic of medical marijuana and its legalization is extremely controversial and the Medical Society has carefully analyzed this issue in light of current scientific evidence. Our physician members are highly trained scientists who use the best of medical research to improve the health of all Pennsylvanians. Good, careful, scientific research takes time. Our current position on the subject of medical marijuana is as follows: further research is needed to build the body of knowledge and evidence base indicating its use by the medical community. This policy mirrors that of the national American Medical Association.
Let me also state in the strongest terms our opposition to the legalization of marijuana for recreational use. Marijuana is a dangerous drug and the public health and safety consequences attendant to its legalization for recreational use would be significant. We acknowledge that there are other states that have or are considering legalizing marijuana for recreational use. Our policy and our comments today should in no way be construed to apply to the legalization of marijuana for recreational use, which the Medical Society sees as an entirely different matter.
Again, to restate our position: we support increased scientific study on the medical use of marijuana. That is to say that until further research clearly demonstrates its safe and effective use in patient care, beyond any reasonable doubt, we urge caution and do not recommend marijuana for medical use in Pennsylvania. We also believe that to enable rigorous research on this topic, the federal Food and Drug Administration should re-examine marijuana’s status as a Schedule 1 controlled substance. Again, this position mirrors that of the national physician’s group, the American Medical Association.
We understand that the legalization of marijuana for medical use is a controversial topic. There is no national consensus: 20 states and the District of Columbia permit it. Only one of these twenty is a neighbor state – New Jersey.
We acknowledge that there is some evidence, primarily anecdotal, that marijuana may provide relief from nausea to cancer patients, and it is asserted that it may aid in the treatment of glaucoma and post-traumatic stress disorder. We are also aware of recent news stories that oil derived from cannabidiol has aided some suffers of Dravet syndrome, a rare form of epilepsy.
We in no way discount the very important experience of those whose lives have been reportedly improved by the use of medical marijuana or its derivates. Instead, we want to focus the discussion on building a better body evidence that allows physicians and other providers to make science-based decisions about the use of marijuana in the treatment of their patients.
Anecdotal evidence is just that – a real, valid, individual experience, but that cannot be applied to other’s experience with great degree of confidence. There is no sure way to know whether the observed changes in one case resulted from the administration of marijuana or from some other source, or combination of sources. It is entirely possible that a case we hear about in which an individual benefited from marijuana may be offset by the case we don't hear about where a patient saw no improvement and, even worse, where a patient suffered harm. Careful, rigorous scientific study is warranted on this important issue. Researchers should be encouraged to begin scientific study of this subject without the constraints of FDA Schedule 1 status.
The first maxim of medical practice that our physician members are taught is this: first do no harm. As they progress in their training they also learn that they are ethically bound to treat patients with the best that medical science recommends. And that is where we are today: at the intersection of the duty to do no harm, and the ethical duty to treat with the best available medicine. You can see why this is an issue requiring further study.
Many Medical Society physicians believe a compelling case exists for a serious scientific examination of the potential medical use of marijuana. That is why four years ago we supported, and continue to support, the American Medical Association in urging that marijuana’s status as a federal Schedule 1 controlled substance be reviewed, with the goal of facilitating the conduct of clinical research and development of cannabinoid-based medicines, and alternate delivery methods.
The AMA and the Medical Society have also called for further adequate, well-controlled studies of marijuana and related cannabinoids in patients who have serious conditions for which preclinical, anecdotal, or controlled evidence suggests possible efficacy, and the application of such results to the understanding and treatment of disease.
Again, thank you for the opportunity to share our views on this important and controversial issue. I will be happy to answer any questions you may have or refer them to the appropriate member of our physician leadership with appropriate medical expertise.

We welcome user discussion on our site, under the following guidelines:

To comment you must first create a profile and sign-in with a verified DISQUS account or social network ID. Sign up here.

Comments in violation of the rules will be denied, and repeat violators will be banned. Please help police the community by flagging offensive comments for our moderators to review. By posting a comment, you agree to our full terms and conditions. Click here to read terms and conditions.